Effect of Probiotics on Metabolic Outcomes in Pregnant Women with Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The metabolic effects of probiotic administration in women with gestational diabetes mellitus (GDM) is unknown. The objective of this review was to investigate the effect of probiotics on fasting plasma glucose (FPG), insulin resistance (HOMA-IR) and LDL-cholesterol levels in pregnant women diagnosed with GDM. Seven electronic databases were searched for RCTs published in English between 2001 and 2017 investigating the metabolic effects of a 6–8 week dietary probiotic intervention in pregnant women following diagnosis with GDM. Eligible studies were assessed for risk of bias and subjected to qualitative and quantitative synthesis using a random effects model meta-analyses. Four high quality RCTs involving 288 participants were included in the review. Probiotic supplementation was not effective in decreasing FBG (Mean Difference = −0.13; 95% CI −0.32, 0.06, p = 0.18) or LDL-cholesterol (−0.16; 95% CI −0.45, 0.13, p = 0.67) in women with GDM. However, a significant reduction in HOMA-IR was observed following probiotic supplementation (−0.69; 95% CI −1.24, −0.14, p = 0.01). There were no significant differences in gestational weight gain, delivery method or neonatal outcomes between experimental and control groups, and no adverse effects of the probiotics were reported. Probiotic supplementation for 6–8 weeks resulted in a significant reduction in insulin resistance in pregnant women diagnosed with GDM. The use of probiotic supplementation is promising as a potential therapy to assist in the metabolic management of GDM. Further high quality studies of longer duration are required to determine the safety, optimal dose and ideal bacterial composition of probiotics before their routine use can be recommended in this patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“The gut microbial composition is altered during pregnancy, and given that specific micro-organisms in the gastrointestinal tract are able to positively influence host metabolism, probiotic supplements may contribute to the maintenance of bacterial diversity and glucose homeostasis in individuals with metabolic disturb…”
BackgroundInflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“The gut microbial composition is altered during pregnancy, and given that specific micro-organisms in the gastrointestinal tract are able to positively influence host metabolism, probiotic supplements may contribute to the maintenance of bacterial diversity and glucose homeostasis in individuals with metabolic disturb…”
BackgroundType 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“A seven-fold increased risk of the mother developing type 2 diabetes (T2DM) postpartum has also been reported [16].”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Kling Bäckhed, H., Gonzalez, A., Werner, J. J., Angenent, L. T., Knight, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.008 · Cited by 2,165 · cited 3×
“Increases in colonic microbial diversity have been linked to improved glucose homeostasis, attenuation of inflammation, regulation of insulin production, maintenance of the integrity of the gastrointestinal lining, and the harvesting of nutrients from the host diet [7,8,27].”
BackgroundHuman gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · cited 1×
“Increases in colonic microbial diversity have been linked to improved glucose homeostasis, attenuation of inflammation, regulation of insulin production, maintenance of the integrity of the gastrointestinal lining, and the harvesting of nutrients from the host diet [7,8,27].”
BackgroundDominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 1×
“Both insulin and metformin are considered safe for use in pregnancy, but can be associated with unwanted side effects such as gastrointestinal disturbances and hypoglycemia [52,53].”
BackgroundTemporal and spatial variation of the human microbiota during pregnancy
DiGiulio, D. B., Callahan, B. J., McMurdie, P. J., Costello, E. K., Lyell, D. J., Robaczewska, A., Sun, C. L., Goltsman, D. S. A., Wong, R. J., Shaw, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502875112 · Cited by 1,129 · cited 1×
“From the first (T1) to the third trimester (T3), the species richness of the gut microbiome decreases [8], although this has not been observed in all studies [10].”
BackgroundIncreased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489
Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota
Cani, P. D., & Delzenne, N. M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.016 · Cited by 377 · cited 1×
“have been reported to play a protective role in the prevention of metabolic perturbations by reducing LPS-induced oxidative stress and low grade chronic inflammation [48].”
BackgroundJayashree, B., Bibin, Y. S., Prabhu, D., Shanthirani, C. S., Gokulakrishnan, K., Lakshmi, B. S., Mohan, V., & Balasubramanyam, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1911-4 · Cited by 353 · cited 1×
“Another hypothesized mechanism of SCFA action includes reducing gastrointestinal permeability by upregulating transcription of tight junction proteins, enhancing production of Glucagon-like peptide-2 (GLP-2) which promotes crypt cell proliferation, and reducing inflammation in colonic epithelial cells by increasing PP…”
BackgroundDiamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308 · cited 1×
“Perturbations in the composition of the gut microbiota have been hypothesized to contribute to the pathogenesis of obesity, inflammation and insulin resistance [9].”
BackgroundKellow, N. J., Coughlan, M. T., & Reid, C. M. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003607 · Cited by 307 · cited 1×
“SCFAs act as an energy source for intestinal cells and have been found to regulate the production of hormones effecting energy intake and expenditure such as leptin and grehlin [40].”
BackgroundSelf-citationFood, immunity, and the microbiome
Tilg, H., & Moschen, A. R. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.036 · Cited by 292 · cited 2×
“The binding of SCFAs to G protein-coupled receptors GPR41 and GPR43 increases the intestinal expression of Peptide YY and Glucagon-like peptide-1 (GLP-1) hormones which act to reduce appetite by slowing intestinal transit time and increasing insulin sensitivity [11].”
BackgroundMetformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222 · cited 1×
“Both insulin and metformin are considered safe for use in pregnancy, but can be associated with unwanted side effects such as gastrointestinal disturbances and hypoglycemia [52,53].”
BackgroundGohir, W., Whelan, F. J., Surette, M. G., Moore, C., Schertzer, J. D., & Sloboda, D. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1086056 · Cited by 203 · cited 1×
“These changes in gut microbial composition cause inflammation and correlate with increases in fat mass, blood glucose, insulin resistance and circulating pro-inflammatory cytokines in the expectant mother [12].”
BackgroundVohr, B. R., & Boney, C. M. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050801929430 · Cited by 184 · cited 1×
“Additionally, studies suggest that children born to mothers with GDM have an increased risk of diabetes mellitus and metabolic dysfunction later in life [19,20].”
BackgroundProbiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis
Samah, S., Ramasamy, K., Lim, S. M., & Neoh, C. F. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.014 · Cited by 112 · cited 2×
“The authors postulated that probiotics may elicit hypoglycemic effects by increasing the level of antioxidative enzymes capable of scavenging reactive oxygen species, thereby reducing oxidative stress levels [44].”
BackgroundProbiotics for preventing gestational diabetes
Barrett, H. L., Dekker Nitert, M., Conwell, L. S., & Callaway, L. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009951.pub2 · Cited by 101
Zhou, Z.-Y., Ren, L.-W., Zhan, P., Yang, H.-Y., Chai, D.-D., & Yu, Z.-W. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.21 · Cited by 92
Feng, Y., & Yang, H. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1228061 · Cited by 68 · cited 1×
“Metformin reduces hyperglycemia by increasing insulin sensitivity and reducing excessive hepatic gluconeogenesis [49].”
Background
Cited by
Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398
RetractedYamamoto, J. M., Kellett, J. E., Balsells, M., García-Patterson, A., Hadar, E., Solà, I., Gich, I., van der Beek, E. M., Castañeda-Gutiérrez, E., Heinonen, S., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0102 · Cited by 301
“We did not include studies of nutritional supplements such as vitamin D or probiotics as recent reviews have addressed these topics (19,20).”
BackgroundFerrocino, I., Ponzo, V., Gambino, R., Zarovska, A., Leone, F., Monzeglio, C., Goitre, I., Rosato, R., Romano, A., Grassi, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30735-9 · Cited by 255
Reappraisal of probiotics’ safety in human
Sotoudegan, F., Daniali, M., Hassani, S., Nikfar, S., & Abdollahi, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.032 · Cited by 154
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116
Metadata
- Authors
- Taylor, B., Woodfall, G., Sheedy, K., O’Riley, M., Rainbow, K., Bramwell, E., & Kellow, N.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-05-05
- Volume
- 9
- Issue
- 5
- Pages
- 461
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2611037949
- Cited by
- 126
- References
- 23
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.